RPL34P34

Across TCGA pan-cancer cohorts, RPL34P34 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPL34P34 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPL34P34 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL34P34 expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

BLCA, SKCM, and MESO are the cancer types where RPL34P34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	II,III,IV	0.671	0.548	.004	71	view →
SKCM	OS	Tertile	All	0.852	0.708	<.001	46	view →
MESO	DFS	Quartile	II,III,IV	0.474	0.262	.007	32	view →
LGG	OS	Tertile	All	0.652	0.420	<.001	26	view →
LUAD	DFS	Tertile	III,IV	0.368	0.784	.002	18	view →
TGCT	DFS	Quartile	II,III,IV	0.554	1.000	.036	16	view →
OV	OS	Tertile	III,IV	0.645	0.732	.012	12	view →
KIRC	OS	Median	All	0.700	0.557	.003	9	view →
CHOL	DFS	Median	II,III,IV	0.609	0.128	.021	8	view →
PRAD	DFS	Tertile	All	0.695	0.862	.025	8	view →
THCA	DFS	Quartile	All	0.972	0.898	.016	8	view →
PAAD	OS	Tertile	II,III,IV	0.465	0.654	.033	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPL34P34–BLCA (OS)

Open the BLCA breakdown →